Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Manise, Maïté ^a   Holtappels, Gabriele ^b   Van Crombruggen, Koen ^b   Schleich, Florence ^a   Bachert, Claus ^b   Louis, Renaud ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DETECTION; ARTICLE; ASTHMA; ATOPY; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GRANULOCYTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OUTCOME ASSESSMENT; PHENOTYPE; PROTEIN DETERMINATION; SMOKING; SPUTUM ANALYSIS; SPUTUM LEVEL; SYNDROME DELINEATION;

ADULT; AGED; ASTHMA; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NEUTROPHILS; SPUTUM;

EID: 84875472707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058388     Document Type: Article

References (49)

1. Simpson JL, Scott R, Boyle MJ, Gibson PG, (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11: 54-61.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, et al. (1990) Eosinophilic inflammation in asthma. N Engl J Med 323: 1033-9.
3. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, et al. (2012) A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 185: 612-9.
4. Gibson PG, Simpson JL, Saltos N, (2001) Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329-36.
5. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ, (1999) Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353: 2213-4.
6. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, et al. (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160: 1001-8.
7. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, et al. (2002) Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57: 875-9.
8. Mouthuy J, Detry B, Sohy C, Pirson F, Pilette C, (2011) Presence in sputum of functional dust mite-specific IgE antibodies in intrinsic asthma. Am J Respir Crit Care Med 184: 206-14.
9. Zhang N, Holtappels G, Gevaert P, Patou J, Dhaliwal B, et al. (2011) Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 66: 141-8.
10. Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, et al. (2010) Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126: 962-8, 968.
11. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, et al. (2001) Regulation of mast cell survival by IgE. Immunity 14: 791-800.
12. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, et al. (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14: 801-11.
13. Bachert C, van Steen K, Zhang N, Holtappels G, Cattaert T, et al. (2012) Specific IgE against Staphylococcus aureus enterotoxins: An independent risk factor for asthma. J Allergy Clin Immunol.
14. Bachert C, Zhang N (2012) Chronic rhinosinusitis and asthma: novel understanding of the role of IgE "above atopy". J Intern Med.
15. Kowalski ML, Cieslak M, Perez-Novo CA, Makowska JS, Bachert C, (2011) Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 66: 32-8.
16. Levy F, Kristofic C, Heusser C, Brinkmann V, (1997) Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int Arch Allergy Immunol 112: 49-58.
17. Takatsu K, Nakajima H, (2008) IL-5 and eosinophilia. Curr Opin Immunol 20: 288-94.
18. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER, (2005) Is the neutrophil the key effector cell in severe asthma? Thorax 60: 529-30.
19. Hoebe K, Janssen E, Beutler B, (2004) The interface between innate and adaptive immunity. Nat Immunol 5: 971-4.
20. Brightling C, Berry M, Amrani Y, (2008) Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 121: 5-10.
21. Louis R, Godinas L, Schleich F (2011) Induced sputum - towards normal values. Non-invasive assessment of airways inflammation in asthma and COPD. 113-24. Paschalidis.
22. Delvaux M, Henket M, Lau L, Kange P, Bartsch P, et al. (2004) Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax 59: 111-5.
23. Fahy JV, Liu J, Wong H, Boushey HA, (1993) Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 147: 1126-31.
24. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, et al. (1996) High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 153: 1931-7.
25. Galli SJ, Maurer M, Lantz CS, (1999) Mast cells as sentinels of innate immunity. Curr Opin Immunol 11: 53-9.
26. Galli SJ, (2000) Mast cells and basophils. Curr Opin Hematol 7: 32-9.
27. Nahm DH, Park HS, (1998) Analysis of induced sputum for studying allergen-specific IgE antibodies in airway secretion from asthmatic patients. Clin Exp Allergy 28: 686-93.
28. O'Byrne PM, Gauvreau GM, Brannan JD, (2009) Provoked models of asthma: what have we learnt? Clin Exp Allergy 39: 181-92.
29. Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, et al. (2009) The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respir Med 103: 1098-113.
30. Douwes J, Gibson P, Pekkanen J, Pearce N, (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57: 643-8.
31. Renauld JC, (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54: 577-89.
32. Takatsu K, Nakajima H, (2008) IL-5 and eosinophilia. Curr Opin Immunol 20: 288-94.
33. Chiba Y, Nakazawa S, Todoroki M, Shinozaki K, Sakai H, et al. (2009) Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am J Respir Cell Mol Biol 40: 159-67.
34. Commins SP, Borish L, Steinke JW, (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 125: S53-S72.
35. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, et al. (2006) IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 117: 269-74.
36. Berry MA, Parker D, Neale N, Woodman L, Morgan A, et al. (2004) Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 114: 1106-9.
37. Erin EM, Jenkins GR, Kon OM, Zacharasiewicz AS, Nicholson GC, et al. (2008) Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants. Am J Respir Crit Care Med 177: 132-41.
38. Park SW, Jangm HK, An MH, Min JW, Jang AS, et al. (2005) Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. Chest 128: 1921-7.
39. Barnes PJ, (2009) Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 39: 1145-51.
40. Berry M, Morgan A, Shaw DE, Parker D, Green R, et al. (2007) Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 62: 1043-9.
41. Bacharier LB, Geha RS, (2000) Molecular mechanisms of IgE regulation. J Allergy Clin Immunol 105: S547-S558.
42. Pelletier M, Micheletti A, Cassatella MA, (2010) Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells. J Leukoc Biol 88: 1163-70.
43. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, et al. (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205: 1551-7.
44. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, et al. (2006) IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 7: 135.
45. Holgate ST, Noonan M, Chanez P, Busse W, Dupont L, et al. (2011) Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J 37: 1352-9.
46. Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, et al. (2009) A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179: 549-58.
47. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, et al. (2006) Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354: 697-708.
48. Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, et al. (2006) The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 174: 753-62.
49. Kelly MM, Keatings V, Leigh R, Peterson C, Shute J, et al. (2002) Analysis of fluid-phase mediators. Eur Respir J Suppl 37: 24s-39s.